Frontlight ResearchEarly access
Type 1 diabetes trials in United States
178 of 217 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peoplePrecision Administration of Anti-thymocyte Globulin With or Without Verapamil
- Where
- Aurora, Gainesville
- Age
- 4 years to 35 years
- People
- 60
- Run by
- University of Florida
See details and how to joinNCT06455319 - Phase 2Taking peoplePharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus
- Where
- Aurora, Birmingham, Chicago, Renton, Walnut Creek
- Age
- 18 years to 50 years
- People
- 72
- Run by
- Op-T LLC
See details and how to joinNCT06964087 - Phase 3Taking peoplePRISE (Personalized Response and Immunologic Surveillance of Endogenous C-Peptide Preservation in New, Recent, and Established Onset Type 1 Diabetes Treated With Human Anti-Thymocyte Globulin [h-ATG]) Study
- Where
- Aurora, Gainesville, Indianapolis, San Francisco
- Age
- 5 years to 40 years
- People
- 108
- Run by
- University of Florida
See details and how to joinNCT07670650 · EU 2025-524787-37-00 - Phase 3Taking peopleOral VK2735 for Weight Management Phase 3 (SUNRISE 1)
- Where
- Abilene, Atlanta, Chula Vista, East Greenwich, Evansville, Henderson, Jackson, Lake Forest, Louisville, Medford, Melbourne, Morehead City, Richfield, Rochester, Salt Lake City, Seattle, Springfield, The Villages, Tucson, Valparaiso
- Age
- 18 years and over
- People
- 560
- Run by
- Viking Therapeutics, Inc.
See details and how to joinNCT07868835 - Phase 3Taking peopleA Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- Where
- Ann Arbor, Asheville, Atlanta, Aurora, Bartlett, Boise, Buffalo, Chapel Hill, Charlottesville, Cincinnati, Columbus, Gainesville, Hollywood, Houston, Idaho Falls, Jacksonville, Kansas City, Louisville, New Haven, New York, Philadelphia, Rochester, Saint Louis Park, Salt Lake City, San Diego, San Francisco, Scottsdale, Seattle, Tacoma, Tampa, Winter Park
- Age
- 1 year to 25 years
- People
- 723 worldwide
- Run by
- Sanofi
See details and how to joinNCT07088068 - No phaseTaking peopleEvaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes
- Where
- Atlanta, Aurora, Austin, Charlottesville, Chula Vista, Escondido, Gainesville, Idaho Falls, New Haven, Palo Alto, Renton, San Antonio, San Diego, San Francisco, Santa Barbara, Seattle, Tampa, Walnut Creek
- Age
- 2 years to 80 years
- People
- 1,500
- Run by
- Medtronic MiniMed, Inc.
See details and how to joinNCT07864168 - No phaseTaking peopleFood Insecurity Reduction & Strategy Team
- Where
- Palo Alto
- Age
- 18 years and over
- People
- 160
- Run by
- Stanford University
See details and how to joinNCT06329375 - Phase 1/2Taking peopleCNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
- Where
- Ann Arbor, Atlanta, Aurora, Austin, Baltimore, Bloomfield Township, Boston, Buffalo, Chattanooga, Chicago, Cleveland, Dallas, Durham, Fort Myers, Gainesville, Greenville, Hialeah, Humble, Idaho Falls, Indianapolis, Jacksonville, Kansas City, Memphis, Miami, Minneapolis, Newport Beach, New York, Raleigh, San Antonio, San Diego, Seattle, Smithfield, Springfield, St Louis, Tampa, Tucson, Walnut Creek, Waxahachie
- Age
- 12 years to 35 years
- People
- 72
- Run by
- COUR Pharmaceutical Development Company, Inc.
See details and how to joinNCT06783309 - No phaseTaking peopleThrive With Type 1 Diabetes 2026
- Where
- Atlanta
- Age
- 31 years to 75 years
- People
- 48
- Run by
- Emory University
See details and how to joinNCT07522866 - No phaseTaking peopleCan Mindfulness and Virtual Reality Reduce Stress in Young Adults With Type 1 Diabetes?
- Where
- Baltimore, Detroit
- Age
- 16 years to 20 years
- People
- 48
- Run by
- Wayne State University
See details and how to joinNCT07793097 - No phaseTaking peopleTo Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.
- Where
- Indianapolis
- Age
- 18 years and over
- People
- 34
- Run by
- Viral N. Shah
See details and how to joinNCT07287943 - Phase 2Taking peopleCadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes Who Are Using Hybrid Closed Loop (HCL) Systems
- Where
- Atlanta, Aurora, Austin, Chapel Hill, Modesto, San Diego
- Age
- 18 years and over
- People
- 40
- Run by
- vTv Therapeutics
See details and how to joinNCT07616206 - Phase 4Taking peoplePermissive Versus Strict Intrapartum Glucose Management in Type 1 and Type 2 Diabetes (PRISM)
- Where
- Columbus
- Age
- 18 years and over
- People
- 44
- Run by
- Ohio State University
See details and how to joinNCT07293715 - Phase 3Taking peopleA Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Where
- Beltsville, Champaign, Chicago, Columbus, Escondido, Fargo, Franklin, Houston, Jacksonville, Kansas City, Las Vegas, Lincoln, Manassas, Oxon Hill, Portland, Renton, Smithfield, Somerset, Statesville, Stockbridge, Walnut Creek, Woodstock
- Age
- 18 years and over
- People
- 500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07776509 · EU 2025-523295-23-00 - No phaseNot yet taking people in United StatesInter-Arm Differences in Continuous Glucose Monitor Readings in Adults With Diabetes
- Where
- Stockton
- Age
- 18 years and over
- People
- 60
- Run by
- University of the Pacific
See details and how to joinNCT07920341 - Phase 3Not yet taking people in United StatesCKM For Safe Use of SGLT2i in Type 1 Diabetes
- Where
- La Jolla
- Age
- 18 years and over
- People
- 52
- Run by
- University of California, San Diego
See details and how to joinNCT07211802 - Phase 3Taking peopleA Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
- Where
- Charlottesville, Iowa City, Louisville, Philadelphia, Santa Barbara, Tallahassee, West Des Moines
- Age
- 1 year to 35 years
- People
- 150 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07222137 · EU 2025-521797-34-00 - Phase 3Taking peopleA Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
- Where
- Aurora, Charlottesville, Corpus Christi, Philadelphia, Tallahassee
- Age
- 1 year to 35 years
- People
- 300 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07222332 · EU 2025-522170-36-00 - No phaseTaking peopleC-Carbs: A CGM-guided Approach to Teaching Carb Awareness
- Where
- Los Angeles
- Age
- 18 years and over
- People
- 40
- Run by
- University of California, Los Angeles
See details and how to joinNCT07807280 - No phaseTaking peopleClosed Loop and Education for Hypoglycemia Awareness Restoration
- Where
- La Jolla, Lexington, Minneapolis, Orlando, Philadelphia
- Age
- 18 years to 75 years
- People
- 324 worldwide
- Run by
- Milton S. Hershey Medical Center
See details and how to joinNCT06325202 - No phaseTaking peopleSupporting Medtronic 780G Insulin Pump Adoption in Latino Patients: A Spanish - Language Training Initiative
- Where
- Aurora
- Age
- 10 years to 20 years
- People
- 15
- Run by
- University of Colorado, Denver
See details and how to joinNCT07720388 - Phase 3Taking peopleA Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Where
- Ames, Arlington, Bridgeport, Butte, Champaign, Chicago, Clearwater, Columbus, Cortland, Dothan, El Dorado, Escondido, Fargo, Houston, Huntsville, Jacksonville, Jefferson City, Jersey City, Kansas City, Kingsport, Las Vegas, Maumee, Memphis, Mesa, Owensboro, Philadelphia, Portland, Renton, Rochester, Rocky Mount, Salt Lake City, San Antonio, Seattle, Smithfield, Statesville, Stockbridge, Sugar Land, Troy, Tulsa, Waco, Wilmington
- Age
- 18 years and over
- People
- 2,500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00 - No phaseTaking peopleStarting Technology in At Risk Type 1 Diabetes Study
- Where
- Santa Monica, Sylmar, Torrance
- Age
- 18 years and over
- People
- 40
- Run by
- University of California, Los Angeles
See details and how to joinNCT06453928 - No phaseNot yet taking people in United StatesCare COMPASS Study
- Where
- Portland
- Age
- 18 years and over
- People
- 200
- Run by
- Fitbit LLC
See details and how to joinNCT07904793 - Phase 4Taking peopleCholesterol Lowering and Residual Risk in Diabetes, Type 1
- Where
- New York
- Age
- 18 years to 89 years
- People
- 125
- Run by
- NYU Langone Health
See details and how to joinNCT05641753